Emergent BioSolutions Inc (NYSE:EBS)

30.89
Delayed Data
As of 2:43pm ET
 +0.46 / +1.51%
Today’s Change
19.31
Today|||52-Week Range
31.75
+13.44%
Year-to-Date

Today’s Trading

Previous close30.43
Today’s open29.54
Day’s range29.00 - 30.93
Volume256,009
Average volume (3 months)274,150
Market cap$1.2B
Dividend yield--
Data as of 2:43pm ET, 05/27/2015

Growth & Valuation

Earnings growth (last year)+3.53%
Earnings growth (this year)+51.20%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+8.49%
P/E ratio40.1
Price/Sales3.00
Price/Book2.07

Competitors

 Today’s
change
Today’s
% change
CLLSCellectis SA+5.23+14.35%
NLNKNewLink Genetics Cor...+1.35+3.23%
ZIOPZIOPHARM Oncology In...+0.13+1.42%
TXMDTherapeuticsMD Inc+0.41+6.57%
Data as of 2:57pm ET, 05/27/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)$0.11
Annual revenue (last year)$339.3M
Annual profit (last year)$36.7M
Net profit margin10.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
Executive VP-Corporate Services
Robert G. Kramer
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers